KD Leisures Limited has announced the resignation of Ms. Anjali from her position as Company Secretary and Compliance Officer, effective from 30th April, 2026 after closure of business hours. The resignation was disclosed to the Bombay Stock Exchange pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Resignation Details

Ms. Anjali, holding Membership No. A77597, submitted her resignation letter citing personal reasons and pursuit of better professional growth opportunities. In her resignation letter dated 30th April, 2026, she expressed gratitude to the management for the support and opportunities extended during her tenure.

Regulatory Compliance

The company has fulfilled all mandatory disclosure requirements under the SEBI Listing Regulations. The disclosure was made in accordance with Schedule III and SEBI Circular No. HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated 30th January, 2026. Annexure-A containing the detailed particulars was submitted to the exchange as part of the regulatory filing.

Company Information

KD Leisures Limited (CIN: L55100MH1981PLC272664) has its registered office at Unit No. 1109, 11th Floor, Lotus Link Square, D.N. Nagar, New Link Road, Andheri (West), Mumbai – 400053. The corporate office is located at B-10/665/1, Iqbal Ganj, Iqbal Ganj Chowk, Ludhiana, Punjab-141008. The disclosure was signed by Deepika Awasthi, Director (DIN: 08624842), on behalf of the company.

KD Leisures Limited's board of directors convened on April 30, 2026, at the company's registered office in Mumbai to approve significant corporate restructuring initiatives. The meeting, which commenced at 4:00 PM and concluded at 5:00 PM, addressed key resolutions including a proposed name change and director regularizations that will require shareholder approval at the upcoming Extra-Ordinary General Meeting.

Board Meeting Outcomes and Corporate Restructuring

The board approved changing the company's name from KD Leisures Limited to Vedic Ayurveda Limited, marking a strategic shift toward the wellness and Ayurvedic sector. This transformation will require consequential alterations to the company's constitutional documents and shareholder approval through a Special Resolution at the EGM.

Director Appointments and Leadership Team

The board regularized three director appointments with diverse expertise in wellness and corporate governance. Ms. Deepika Awasthi (DIN: 08624842) was regularized as Executive Director, bringing over 15 years of experience in astrology, numerology, and tarot reading. Her appointment was initially approved on February 2, 2026, with regularization effective April 30, 2026.

Ms. Kanchan Yadav will serve as Non-Executive Independent Director for a five-year term, bringing fresh perspective with her graduation from Veer Bahadur Singh Purvanchal University and keen interest in business administration. Ms. Anubha Kumari Sinha, holding a Master's degree, contributes analytical expertise to ensure robust corporate governance.

Business Expansion into Wellness Sector

The board approved significant alterations to the Memorandum of Association by adding three new business objects focused on the wellness and Ayurvedic sector. The expanded scope includes manufacturing, processing, and distributing Ayurvedic, herbal, natural, and wellness products including medicines, supplements, oils, and personal care items.

The company plans to establish wellness centers, Ayurvedic clinics, therapy centers, spas, and healthcare facilities offering treatments, consultations, and holistic healing services. Business operations will extend through physical stores, e-commerce platforms, mobile applications, and digital channels to reach broader markets.

Regulatory Compliance and Documentation

The board meeting was conducted pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. All three directors have been confirmed as not debarred from holding office by virtue of any order of SEBI or any other regulatory authority, ensuring compliance with BSE Circular No. LIST/COMP/14/2018.